ArticleFrontiers in oncology2023

Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with

Giulia Martini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.